Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;37:630-634

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ichihara, A.
Right arrow Articles by Saruta, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ichihara, A.
Right arrow Articles by Saruta, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(D)-PENICILLAMINE
*THIOUREA
Related Collections
Right arrow Hypertension - basic studies
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2001;37:630.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Superoxide Inhibits Neuronal Nitric Oxide Synthase Influences on Afferent Arterioles in Spontaneously Hypertensive Rats

Atsuhiro Ichihara; Matsuhiko Hayashi; Nobuhisa Hirota; Takao Saruta

From the Internal Medicine, Keio University School of Medicine, Tokyo, Japan.

Correspondence to Dr Takao Saruta, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail saruta{at}med.keio.ac.jp

This study was designed to determine the influence of increased superoxide anion in neuronal nitric oxide synthase (nNOS)-dependent regulation of afferent arterioles in spontaneously hypertensive rats (SHR). Afferent arteriolar diameters of male Wistar-Kyoto rats (WKY) and SHR were assessed in vitro with the blood-perfused juxtamedullary nephron technique and averaged 21.6±1.6 (n=6) and 18.8±1.2 (n=7) µm, respectively. The superoxide dismutase mimetic Tempol (1, 10, and 100 µmol/L) did not influence afferent arterioles of WKY but significantly increased afferent arteriolar diameters of SHR by 20.6±5.5%, 25.2±5.4%, and 23.3±4.9%, respectively. In WKY (n=6), the nNOS inhibitor S-methyl-L-thiocitrulline (L-SMTC; 10 µmol/L) and the NOS inhibitor N{omega}-nitro-L-arginine (L-NNA; 100 µmol/L) significantly decreased afferent arteriolar diameters (19.6±1.6 µm) by 11.9±3.1% and 21.0±3.9%, respectively. In SHR (n=7), L-SMTC did not influence afferent arteriolar diameters (21.0±1.5 µm), but L-NNA exerted an afferent arteriolar constriction (14.8±3.2%) that was similar to the response observed in WKY. Experiments were also performed in the presence of 100 µmol/L Tempol. In afferent arterioles of WKY (n=6), Tempol treatment did not modulate the basal diameters (21.5±1.2 µm) or the constrictor response to L-SMTC (10.6±2.1%) or L-NNA (19.3±3.3%). In SHR (n=8), Tempol significantly increased afferent arteriolar diameters by 22.5±4.3% and enhanced afferent arteriolar constrictor responses to L-SMTC (18.4±2.7%) and L-NNA (31.9±2.6%). However, the nitric oxide donor S-nitroso-N-acetylpenicillamine (10 µmol/L), which similarly increased afferent arteriolar diameters (17.2±2.3%, n=6), did not affect afferent arteriolar responses to L-SMTC (1.5±2.7%) or L-NNA (18.6±2.3%). These suggest that superoxide anion inhibits the control of afferent arteriolar diameters by nNOS in SHR.


Key Words: Tempol • nitric oxide synthase • arterioles • rats, spontaneously hypertensive • kidney




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
C. S. Wilcox and A. Pearlman
Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides
Pharmacol. Rev., December 1, 2008; 60(4): 418 - 469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. E. Patterson, J. J. Mullins, and K. D. Mitchell
Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F205 - F211.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. V. Cuong, M. Warda, N. Kim, W. S. Park, J. H. Ko, E. Kim, and J. Han
Dynamic changes in nitric oxide and mitochondrial oxidative stress with site-dependent differential tissue response during anoxic preconditioning in rat heart
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1457 - H1465.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Just, A. J. M. Olson, C. L. Whitten, and W. J. Arendshorst
Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H83 - H92.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. T. de Richelieu, C. M. Sorensen, N.-H. Holstein-Rathlou, and M. Salomonsson
NO-independent mechanism mediates tempol-induced renal vasodilation in SHR
Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1227 - F1234.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. K. Fellner and W. J. Arendshorst
Angiotensin II, reactive oxygen species, and Ca2+ signaling in afferent arterioles
Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1012 - F1019.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Li, T. Jue, J. Edwards, X. Wang, and T. H. Hintze
Changes in NO bioavailabilty regulate cardiac O2 consumption: control by intramitochondrial SOD2 and intracellular myoglobin
Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H47 - H54.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Zimpelmann, N. Li, and K. D. Burns
Nitric oxide inhibits superoxide-stimulated urea permeability in the rat inner medullary collecting duct
Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1160 - F1167.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. Makino, M. M. Skelton, A.-P. Zou, and A. W. Cowley Jr
Increased Renal Medullary H2O2 Leads to Hypertension
Hypertension, July 1, 2003; 42(1): 25 - 30.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda and T. Okamura
The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels
Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. F. Reckelhoff and J. C. Romero
Role of oxidative stress in angiotensin-induced hypertension
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R893 - R912.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Ichihara, M. Hayashi, Y. Koura, Y. Tada, T. Sugaya, N. Hirota, and T. Saruta
Blunted Tubuloglomerular Feedback by Absence of Angiotensin Type 1A Receptor Involves Neuronal NOS
Hypertension, December 1, 2002; 40(6): 934 - 939.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. G. Schnackenberg
Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R335 - R342.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Ren, O. A. Carretero, and J. L. Garvin
Mechanism by Which Superoxide Potentiates Tubuloglomerular Feedback
Hypertension, February 1, 2002; 39(2): 624 - 628.
[Abstract] [Full Text] [PDF]